Evidence map›Paper›PMID 23186943›Full record

ArticleOsteoarthritis and cartilage2013

Effects of doxycycline on mesenchymal stem cell chondrogenesis and cartilage repair.

Hannah H Lee, Michael J O'Malley, Nicole A Friel, Constance R Chu

Open access · greenAbstract read
In one paragraph

Article in Osteoarthritis and cartilage, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Tetracycline use in treating osteoarthritis: a systematic review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hannah H Lee *Cartilage Restoration Center, Department of Orthopaedic Surgery, University of Pittsburgh, Pennsylvania, USA.
Michael J O'Malley *Cartilage Restoration Center, Department of Orthopaedic Surgery, University of Pittsburgh, Pennsylvania, USA.
Nicole A FrielCartilage Restoration Center, Department of Orthopaedic Surgery, University of Pittsburgh, Pennsylvania, USA.
Constance R ChuCartilage Restoration Center, Department of Orthopaedic Surgery, University of Pittsburgh, Pennsylvania, USA.
University of Pittsburgh · US

Funding

Cellular Approaches to Tissue Engineering/RegenerationT32EB001026 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUNCAN, ANDREW W, MONGA, SATDARSHAN SINGH · 2003 to 2024
$5.5M
Enhanced Clinical Diagnosis of Early OsteoarthritisR01AR052784 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHU, CONSTANCE R · 2006 to 2015
$4.1M
Chondrogenesis In SituR01AR051963 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHU, CONSTANCE R · 2007 to 2011
$1.9M
Multicenter Cartilage Repair Preclinical Trial in HorsesRC2AR058929 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHU, CONSTANCE R · 2009 to 2010
$1.7M
NIAMS NIH HHS R01 AR051963NIAMS NIH HHS R01 AR052784NIAMS NIH HHS RC2 AR058929NIBIB NIH HHS T32 EB001026NIBIB NIH HHS T32-EB001026
6 · The paper itself

Abstract

objectiveStrategies to improve cartilage repair tissue quality after bone marrow cell-based procedures may reduce later development of osteoarthritis. Doxycycline is inexpensive, well-tolerated, and has been shown to reduce matrix-metalloproteinases (MMPs) and osteoarthritis progression. This study tests the hypotheses that doxycycline reduces MMP, enhances chondrogenesis of human bone marrow-derived mesenchymal stem cells (hMSC), and improves in vivo cartilage repair.

designNinety hMSC pellets were cultured in chondrogenic media with either 0-, 1- or 2-μg/mL doxycycline. Pellets were evaluated with stereomicroscopy, proteoglycan assay, qRT-PCR, and histology. Osteochondral defects (OCDs) were created in the trochlear grooves of 24-Sprague-Dawley rats treated with/without oral doxycycline. Rats were sacrificed at 12-weeks and repair tissues were examined grossly and histologically.

resultshMSC pellets with 1-μg/mL (P = 0.014) and 2-μg/mL (P = 0.002) doxycycline had larger areas than pellets without doxycycline. hMSC pellets with 2-μg/mL doxycycline showed reduced mmp-13 mRNA (P = 0.010) and protein at 21-days. Proteoglycan, DNA contents, and mRNA expressions of chondrogenic genes were similar (P > 0.05). For the in vivo study, while the histological scores were similar between the two groups (P = 0.116), the gross scores of the OCD repair tissues in doxycycline-treated rats were higher at 12-weeks (P = 0.017), reflective of improved repair quality. The doxycycline-treated repairs also showed lower MMP-13 protein (P = 0.029).

conclusionsThis study shows that doxycycline improves hMSC chondrogenesis and decreases MMP-13 in pellet cultures and within rat OCDs. Doxycycline exerted no negative effect on multiple measures of chondrogenesis and cartilage repair. These data support potential use of doxycycline to improve cartilage repair to delay the onset of osteoarthritis.

Indexed as

AnimalsCartilage, ArticularCell DifferentiationCell ProliferationCells, CulturedChondrogenesisDisease Models, AnimalDoxycyclineHumansIn Vitro TechniquesMatrix Metalloproteinase 13Mesenchymal Stem CellsRatsRats, Sprague-DawleyTime FactorsDoxycyclineMatrix Metalloproteinase 13

Identifiers

PMID23186943
PMCPMC5395099
OpenAlexW2085698819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.